Investigation of survival and migration potential of differentiated cardiomyocytes transplanted with decellularized heart scaffold

Abstract

Mesenchymal stem cell‐derived cardiomyocytes are employed as a source for myocardial cell transplantation as well as for tissue engineering in decellularized tissue scaffolds. The present study aimed at investigating the survival and migration potential of differentiated cardiomyocytes integrated to decellularized scaffolds after implantation into retroperitoneum of rats, and to assess the feasibility of their ectopic use for future cardiovascular tissue engineering. For this purpose, adipose tissue‐derived mesenchymal stem cells (AdMSCs) were first isolated. Cells were labeled by bromodeoxyuridine (BrdU). Decellularized cardiac tissue scaffolds were acquired by application of ionic and non‐ionic detergents and the labeled differentiated cells were seeded onto these tested decellularized scaffolds. After 1, 2, and 4 weeks of implantation, either cell free scaffold (CFS) or cell scaffold (CS) composites were examined by various techniques for ectopic migration potential of the implanted cells and interaction between the seeded cells on scaffolds. Throughout the first and second weeks of implantation, positively stained cells were observed in renal tissue samples. Observations, for cardiomyocytes‐specific gene expression during weeks 1, 2, and 4, showed potential increased over each time period. A reverse transcription polymerase chain reaction (RT‐PCR) results revealed an increased interaction between cells seeded on scaffolds, however CFS test groups showed no significant difference in gene expression. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 561–570, 2019.

In Vivo Micro‐Computerized Tomography Tracking of Human Periodontal Ligament Stem Cells Labeled with Gold Nanocomplexes

“…To successfully apply hPDLSCs to stem cell therapy, it is crucial to monitor and track the transplanted cells in vivo and distinguish whether cellular regeneration is originated from the exogenous cell source. [ 16,17 ] To achieve this, cell labeling agents are commonly used, such as bromodeoxyuridine (BrdU), [ 18 ] superparamagnetic iron oxide nanoparticles (SPIONs), [ 19 ] and fluorescent agents [ 20,21 ] like green fluorescent protein (GFP). [ 22 ] However, BrdU is dependent on immunohistochemical (IHC) analysis.…”

Research hotspots and emerging trends of mesenchymal stem cells in cardiovascular diseases: a bibliometric-based visual analysis

“…Currently, biomaterials technology combined with cellular therapy plays a huge role in cardiovascular diseases ( 165 , 166 ). For example, treatments with collagen can promote cardiomyogenic differentiation of MSCs ( 167 , 168 ).…”

Human SMILE-Derived Stromal Lenticule Scaffold for Regenerative Therapy: Review and Perspectives

“…A recent study transplanting labeled cell-loaded testis scaffolds showed appropriate cell migration to the recipient tissue, indicating that a testicular ECM scaffold could be a promising vehicle to support cell transplantation [ 102 ]. A decellularized heart tissue scaffold was also reported to successfully deliver exogenous cardiomyocytes to the retroperitoneum of recipient animals [ 103 ].…”